These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: A nationwide population-based study. Labaf A; Svensson PJ; Renlund H; Jeppsson A; Själander A Am Heart J; 2016 Nov; 181():1-9. PubMed ID: 27823679 [TBL] [Abstract][Full Text] [Related]
8. Influence of warfarin on cardiac and cerebrovascular events following bioprosthetic aortic valve replacement: A nationwide cohort study. Chang WT; Ho CH; Chang CL; Cheng BC; Wu NC; Chen ZC J Thorac Cardiovasc Surg; 2020 May; 159(5):1730-1739.e1. PubMed ID: 31208804 [TBL] [Abstract][Full Text] [Related]
10. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis. Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements. Pasciolla S; Zizza LF; Le T; Wright K Clin Drug Investig; 2020 Sep; 40(9):839-845. PubMed ID: 32607688 [TBL] [Abstract][Full Text] [Related]
12. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED; J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973 [TBL] [Abstract][Full Text] [Related]
14. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience. Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors. Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264 [TBL] [Abstract][Full Text] [Related]
16. Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves. Huang Y; Schaff HV; Swarna KS; Sangaralingham LR; Nishimura RA; Dearani JA; Crestanello JA; Greason KL Mayo Clin Proc; 2023 Dec; 98(12):1797-1808. PubMed ID: 38043997 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China. Zhang H; Dong Y; Ao X; Fu B; Dong L; Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891 [TBL] [Abstract][Full Text] [Related]
19. Outcomes following transcatheter aortic valve replacement in the United States. Mack MJ; Brennan JM; Brindis R; Carroll J; Edwards F; Grover F; Shahian D; Tuzcu EM; Peterson ED; Rumsfeld JS; Hewitt K; Shewan C; Michaels J; Christensen B; Christian A; O'Brien S; Holmes D; JAMA; 2013 Nov; 310(19):2069-77. PubMed ID: 24240934 [TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical heart valves: a tertiary hospital-based study in Botswana. Botsile E; Mwita JC Cardiovasc J Afr; 2020; 31(4):185-189. PubMed ID: 32181794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]